Vivos Therapeutics Raises $4.64 Million from Warrant Exercise

Vivos Therapeutics closed the exercise of warrants for $4.64 million in gross proceeds. The company issued new unregistered warrants to purchase up to 3,964,712 shares of common stock at an exercise price of $2.09 per share. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. Vivos intends to use the net proceeds for working capital and general corporate purposes.